Podcast: Ensuring the continued success of the postbiotic market

By Olivia Brown

- Last updated on GMT

Getty images
Getty images
Aubrey Levitt, CEO and co-founder of Postbiotics Plus Research, speaks to NutraIngredients about the current market growth of postbiotics, but underlines the key areas that should be addressed by the industry to ensure the continued success of the category.

Highlighting the sudden growth in the number of published studies on postbiotics, Levitt notes a report that predicted the market to reach $24.03 million by 2029 (Meticulous Research).

With regards to further growth, she emphasises the importance of communication and re-educating consumers on the benefits of heat-killed bacteria compared with live strains.

In addition, she says there needs to be clear communication of the specific benefits postbiotics can bring, as well as continual clinical research to enhance the clarity of these benefits.

With regards to key concerns around consumers understanding of postbiotics, she explains: “I don't believe that consumers have to fully understand a category to be interested in it or to have that category grow.

“Understanding the clinical research as this category grows is going to be extremely helpful in understanding how these products will provide a benefit. If these products solve a problem for the consumer, then that’s going to give the category the impetus to grow.”

 She spotlights examples of the numerous consumer groups who would benefit from postbiotics, including those with low fibre diets, those taking antibiotics or other medications, as well as the immunocompromised who cannot consume live bacteria.

In addition, she notes the range of benefits of the category for the industry, including increased shelf stability, ease of production, packaging, and storage, as well as the opportunity for the inclusion bacteria that had been previously difficult to grow.

Related products

show more

Unlock sensory innovation with AromatiQ™ technology

Unlock sensory innovation with AromatiQ™ technology

Content provided by Lonza | 20-Sep-2024 | Product Brochure

With 70% of consumers willing to pay a premium for a more enjoyable and memorable supplement experience, Lonza’s new AromatiQ™ technology enables brands...

From Biofarma a clinically tested vaginal protection

From Biofarma a clinically tested vaginal protection

Content provided by Biofarma Group | 05-Sep-2024 | Product Brochure

Bacterial vaginosis is considered the most common cause of vaginal infection among pregnant and non-pregnant women. In this scenario, the oral intake of...

Embrace Active Aging and ENJOY life!

Embrace Active Aging and ENJOY life!

Content provided by IFF | 05-Sep-2024 | Product Brochure

Live life to the fullest, regardless of age. Our science-backed formulas, packed with clinically studied probiotics and botanicals, empower you to age...

Related suppliers

Follow us

Products

View more

Webinars